advertisement
Katz LJ 9
Showing records 1 to 9 | Display all abstracts from Katz LJ86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Berdahl J
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Razeghinejad R
Survey of Ophthalmology 2020; 65: 530-547
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Voskanyan L
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Lin MM
Survey of Ophthalmology 2020; 65: 530-547
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Myers JS
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Lee D
Survey of Ophthalmology 2020; 65: 530-547
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Katz LJ
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Katz LJ; Myers JS
Survey of Ophthalmology 2020; 65: 530-547
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Samuelson TW
Clinical and Experimental Ophthalmology 2020; 48: 767-774
